ArticleFrontiers in immunology2026

The safety and efficacy of human umbilical cord mesenchymal stem cell for acute respiratory distress syndrome: an open-label and multicenter phase 1 clinical trial.

Qinggang Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.